We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Bionaut Labs Stock

Invest in or calculate the value of your shares in Bionaut Labs or other pre-IPO companies through EquityZen's platform.

Get Started

Bionaut Labs Stock (BILA)

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

About Bionaut Labs Stock

Founded

2016

Headquarters

Los Angeles, CA, US

Industries

Science and Engineering, Health Care, Biotechnology

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.

Bionaut Labs Management

Leadership team at Bionaut Labs

CEO and Co-Founder

Michael Shpigelmacher

Chief Scientific Officer

Alex Kiselyov

Locked Features

Join now and verify your accreditation status to gain access to:

  • Bionaut Labs current valuation
  • Bionaut Labs stock price
  • Available deals in Bionaut Labs and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Bionaut Labs Stock

How to invest in Bionaut Labs stock?

Accredited investors can buy pre-IPO stock in companies like Bionaut Labs through EquityZen funds. These investments are made available by existing Bionaut Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Bionaut Labs stock?

Shareholders can sell their Bionaut Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."